Neuralink's latest publicly disclosed primary financing record is a Undisclosed Series E - II dated May 6, 2026. The event is shown on the company page using the event date—not the date Captables published this historical profile.
Other named participants include Oman Investment Authority.
The preceding primary records in the ledger are $650M Series E dated May 27, 2025; $323.24M Series D dated August 7, 2023; $210M Series C dated July 30, 2021. These entries describe disclosed company financings; they do not include every secondary trade, employee tender, valuation mark or rumored transaction unless those events are separately labeled in the company ledger.
Neuralink is ranked number 45 in the Captables Private 100 source universe. It operates in Neurotechnology and is based in United States. Its $9.00B ranking value is a third-party snapshot and should not be treated as a current executable share price or as the valuation for this round.
The round is currently supported by a public financing-database entry rather than an issuer filing, so Captables labels it as database-listed evidence. This page is a public-source reconstruction, not the issuer's stock ledger or legal capitalization table; undisclosed terms remain undisclosed and readers can submit stronger evidence for editorial review.